Vanguard Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-821,457
| Closed | -$15.6M | – | 4240 |
|
|
2019
Q1 | $15.6M | Buy |
821,457
+18,479
| +2% | +$351K | ﹤0.01% | 2617 |
|
|
2018
Q4 | $10.8M | Buy |
802,978
+87,962
| +12% | +$1.19M | ﹤0.01% | 2737 |
|
|
2018
Q3 | $7.94M | Buy |
+715,016
| New | +$7.94M | ﹤0.01% | 3034 |
|
|
2017
Q1 | – | Sell |
-721,743
| Closed | -$3.54M | – | 4124 |
|
|
2016
Q4 | $3.54M | Sell |
721,743
-3,874
| -0.5% | -$19K | ﹤0.01% | 3180 |
|
|
2016
Q3 | $3.6M | Buy |
725,617
+8,465
| +1% | +$42K | ﹤0.01% | 3153 |
|
|
2016
Q2 | $3.65M | Sell |
717,152
-3,202
| -0.4% | -$16.3K | ﹤0.01% | 3121 |
|
|
2016
Q1 | $4.11M | Buy |
720,354
+22,378
| +3% | +$128K | ﹤0.01% | 3065 |
|
|
2015
Q4 | $7.25M | Buy |
697,976
+22,766
| +3% | +$236K | ﹤0.01% | 2814 |
|
|
2015
Q3 | $12.5M | Buy |
675,210
+29,216
| +5% | +$540K | ﹤0.01% | 2487 |
|
|
2015
Q2 | $12.6M | Sell |
645,994
-967
| -0.1% | -$18.8K | ﹤0.01% | 2558 |
|
|
2015
Q1 | $11.4M | Buy |
646,961
+22,591
| +4% | +$397K | ﹤0.01% | 2585 |
|
|
2014
Q4 | $9.98M | Buy |
624,370
+11,247
| +2% | +$180K | ﹤0.01% | 2538 |
|
|
2014
Q3 | $7.72M | Buy |
613,123
+27,791
| +5% | +$350K | ﹤0.01% | 2612 |
|
|
2014
Q2 | $9.14M | Sell |
585,332
-3,040
| -0.5% | -$47.5K | ﹤0.01% | 2545 |
|
|
2014
Q1 | $7.73M | Buy |
588,372
+40,285
| +7% | +$529K | ﹤0.01% | 2609 |
|
|
2013
Q4 | $8.81M | Buy |
548,087
+32,068
| +6% | +$516K | ﹤0.01% | 2522 |
|
|
2013
Q3 | $8.59M | Sell |
516,019
-10,673
| -2% | -$178K | ﹤0.01% | 2469 |
|
|
2013
Q2 | $5.3M | Buy |
+526,692
| New | +$5.3M | ﹤0.01% | 2633 |
|